Sign In to Follow Application
View All Documents & Correspondence

Peroxisome Proliferator Activated Receptor Alpha Agonist Compounds

Abstract: The present invention is directed to compounds represented by the following structural formula, and pharmaceutically acceptable salts, solvates and hydrates thereof, R1 is a substituted or unsubstituted group selected from C1-C8 alkyl, aryl-C0-2-alkyl, heteroaryl-C0-2-alkyl, C3-C6 cycloalkylaryl-C0-2-alkyl or phenyl. W is O or S. R2 is H or a substituted or unsubstituted group selected from C1-C6 alkyl, C3-C6 cycloalkyl and heteroaryl. X is a C2-C5 alkylene linker wherein one carbon atom of the linker may be replaced with O, NH or S. Y is C, O, S, NH or a single bond. Furthermore, E is (CH2)nCOOH, wherein n is 0, 1, 2 or 3, or C(R3)(R4)A, wherein A is an acidic functional group such as carboxyl, carboxamide substituted or unsubstituted sulfonamide, or substituted or unsubstituted tetrazole. R3 is H, saturated or unsaturated C1-C5 alkyl, C1-C5 alkoxy. Additionally, R4 is H, halo, a substituted or unsubstituted group selected from C1-C5 alkyl, C1-C5 alkoxy, C3-C6 cycloalkyl, arylC0-C4alkyl and phenyl, or R3 and R4 are combined to form a C3-C4 cycloalkyl.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
07 June 2007
Publication Number
32/2007
Publication Type
INA
Invention Field
PHARMACEUTICALS
Status
Email
Parent Application

Applicants

ELI LILLY AND COMPANY
LILLY CORPORATE CENTER, DC 1104, INDIANAPOLIS, IN

Inventors

1. MANTLO, NATHAN, BRYAN
7325 EAST 800 NORTH, BROWNSBURG, IN 46112
2. COLLADO CANO, IVAN
LILLY S.A., AVDA. INDUSTRIA, 30, E-28108 ALCOBENDAS-MADRID
3. DOMINIANNI, SAMUEL, JAMES
7873 CLEARWATER COVE, DRIVE, INDIANAPOLIS, IN 46240
4. ETGEN, GARRET, JAY, JUNIOR
13763 ADIOS PASS, CARMEL, IN 46032
5. GARCIA-PAREDES, CRISTINA
LILLY S.A., AVDA. INDUSTRIA, 30, E-28108 ALCOBENDAS-MADRID
6. JOHNSTON, RICHARD, DUANE
3712 FOREST LANE, GREENFIELD, IN 46140
7. LETOURNEAU, MICHAEL, EDWARD
6024 MCCLELLAN COURT, INDIANAPOLIS, IN 46254
8. MARTINELLI, MICHAEL, JOHN
1935 MULSANNE DRIVE, ZIONSVILLE, IN 46077
9. MAYHUGH, DANIEL, RAY
9681 TROON COURT, CARMEL, IN 46032
10. SAEED, ASHRAF
1500 WORCESTER ROAD, APARTMENT 428, FRAMINGHAM, MA 01702
11. THOMPSON, RICHARD, CRAIG
763 NORTH 900 WEST, FRANKFORT, IN 46041
12. WANG, XIADONG
14066 HONEY TREE DRIVE, CARMEL, IN 46032
13. COFFEY, DAVID, SCOTT
6246 TENNISON WAY, INDIANAPOLIS, IN 46236
14. SCHMID, CHRISTOPHER, RANDALL
6235 CENTRAL AVENUE, INDIANAPOLIS, IN 46220
15. VICENZI, JEFFREY, THOMAS
49 TIMBER LANE, BROWNSBURG, IN 46112
16. XU, YANPING
13832 BARNETT PLACE, FISHERS, IN 46038

Specification

The present invention is directed to compounds represented by the following structural formula, and pharmaceutically acceptable salts, solvates and hydrates thereof, R1 is a substituted or unsubstituted group selected from C1-C8 alkyl, aryl-C0-2-alkyl, heteroaryl-C0-2-alkyl, C3-C6 cycloalkylaryl-C0-2-alkyl or phenyl. W is O or S. R2 is H or a substituted or unsubstituted group selected from C1-C6 alkyl, C3-C6 cycloalkyl and heteroaryl. X is a C2-C5 alkylene linker wherein one carbon atom of the linker may be replaced with O, NH or S. Y is C, O, S, NH or a single bond. Furthermore, E is (CH2)nCOOH, wherein n is 0, 1, 2 or 3, or C(R3)(R4)A, wherein A is an acidic functional group such as carboxyl, carboxamide substituted or unsubstituted sulfonamide, or substituted or unsubstituted tetrazole. R3 is H, saturated or unsaturated C1-C5 alkyl, C1-C5 alkoxy. Additionally, R4 is H, halo, a substituted or unsubstituted group selected from C1-C5 alkyl, C1-C5 alkoxy, C3-C6 cycloalkyl, arylC0-C4alkyl and phenyl, or R3 and R4 are combined to form a C3-C4 cycloalkyl.

Documents

Application Documents

# Name Date
1 2065-KOLNP-2007-ABSTRACT-1.pdf 2018-09-20
1 abstract-02065-kolnp-2007.jpg 2011-10-07
2 02065-kolnp-2007-pct request form.pdf 2011-10-07
2 2065-KOLNP-2007-CLAIMS-1.pdf 2018-09-20
3 2065-KOLNP-2007-DESCRIPTION (COMPLETE)-1.pdf 2018-09-20
3 02065-kolnp-2007-international search report.pdf 2011-10-07
4 2065-KOLNP-2007-DESCRIPTION (COMPLETE)-2.pdf 2018-09-20
4 02065-kolnp-2007-international publication.pdf 2011-10-07
5 2065-KOLNP-2007-DESCRIPTION (COMPLETE)-3.pdf 2018-09-20
5 02065-kolnp-2007-form 5.pdf 2011-10-07
6 2065-KOLNP-2007-DESCRIPTION (COMPLETE)-4.pdf 2018-09-20
6 02065-kolnp-2007-form 3.pdf 2011-10-07
7 2065-KOLNP-2007-ABSTRACT.pdf 2017-03-10
7 02065-kolnp-2007-form 3 1.1.pdf 2011-10-07
8 2065-KOLNP-2007-CLAIMS.pdf 2017-03-10
8 02065-kolnp-2007-form 2.pdf 2011-10-07
9 02065-kolnp-2007-form 18.pdf 2011-10-07
9 2065-KOLNP-2007-ABANDONED LETTER.pdf 2017-01-19
10 02065-kolnp-2007-form 1.pdf 2011-10-07
10 2065-KOLNP-2007-FIRST EXAMINATION REPORT.pdf 2017-01-19
11 2065-KOLNP-2007-ABANDONED LETTER.pdf 2016-10-05
12 02065-kolnp-2007-correspondence others.pdf 2011-10-07
12 2065-KOLNP-2007_EXAMREPORT.pdf 2016-06-30
13 02065-kolnp-2007-abstract.pdf 2011-10-07
13 02065-kolnp-2007-correspondence others 1.1.pdf 2011-10-07
14 02065-kolnp-2007-claims.pdf 2011-10-07
15 02065-kolnp-2007-abstract.pdf 2011-10-07
15 02065-kolnp-2007-correspondence others 1.1.pdf 2011-10-07
16 02065-kolnp-2007-correspondence others.pdf 2011-10-07
16 2065-KOLNP-2007_EXAMREPORT.pdf 2016-06-30
17 2065-KOLNP-2007-ABANDONED LETTER.pdf 2016-10-05
18 2065-KOLNP-2007-FIRST EXAMINATION REPORT.pdf 2017-01-19
18 02065-kolnp-2007-form 1.pdf 2011-10-07
19 2065-KOLNP-2007-ABANDONED LETTER.pdf 2017-01-19
19 02065-kolnp-2007-form 18.pdf 2011-10-07
20 02065-kolnp-2007-form 2.pdf 2011-10-07
20 2065-KOLNP-2007-CLAIMS.pdf 2017-03-10
21 02065-kolnp-2007-form 3 1.1.pdf 2011-10-07
21 2065-KOLNP-2007-ABSTRACT.pdf 2017-03-10
22 02065-kolnp-2007-form 3.pdf 2011-10-07
22 2065-KOLNP-2007-DESCRIPTION (COMPLETE)-4.pdf 2018-09-20
23 02065-kolnp-2007-form 5.pdf 2011-10-07
23 2065-KOLNP-2007-DESCRIPTION (COMPLETE)-3.pdf 2018-09-20
24 02065-kolnp-2007-international publication.pdf 2011-10-07
24 2065-KOLNP-2007-DESCRIPTION (COMPLETE)-2.pdf 2018-09-20
25 02065-kolnp-2007-international search report.pdf 2011-10-07
25 2065-KOLNP-2007-DESCRIPTION (COMPLETE)-1.pdf 2018-09-20
26 2065-KOLNP-2007-CLAIMS-1.pdf 2018-09-20
26 02065-kolnp-2007-pct request form.pdf 2011-10-07
27 abstract-02065-kolnp-2007.jpg 2011-10-07
27 2065-KOLNP-2007-ABSTRACT-1.pdf 2018-09-20